LG / Eaton / 3Joint / Saskatchewan Cancer Agency / Zauber AG / Spiegel / Steingart AB / Merck / Ford / /
Country
United States / Canada / Denmark / /
Currency
pence / USD / / /
Event
FDA Phase / Product Issues / Product Recall / /
Facility
Sir Mortimer B. Davis-Jewish General Hospital / McGill University / /
IndustryTerm
chemical structures / healthcare services / /
MedicalCondition
ovarian cancer / lymphoma / alcohol abuse / immunologic and endocrine dysfunction / female breast cancer / carcinoma / non-melanoma skin cancer / J Cancer / Major depression / epithelial ovarian cancer / breast cancer / second primary cancers / cancers / Cancer / invasive female breast cancer / tumors / chronic depression / breast neoplasms / tumour / depression / radiation-induced cancers / /
MedicalTreatment
radiation / /
NaturalFeature
Saskatchewan / Tsuang MT / /
Organization
Davis-Jewish General Hospital Ethics Committee / Cross Agency Study Committee of Saskatchewan Health / Government of Saskatchewan / Centre for Clinical Epidemiology and Community Studies / McGill University / Internal Review Board / Sir Mortimer B. Davis-Jewish General Hospital / Department of Health / International Agency for Research / /
Person
Van Schaik / Mortimer B Davis-Jewish / Palmer JR / /
Position
Walker / physician / single logistic model to control possible confounding / Hunter / Fireman / /
Product
Antidepressant medication / Do / Epidemiology Nongenotoxic TCAsa Tricyclic / Saskatchewan Prescription Drug Tricyclic / Amoxapine / Tricyclic / bias / Exception Drug / /
British Journal of Cancer[removed], 92 – 97 ª 2002 The Cancer Research Campaign All rights reserved 0007 – [removed] $25.00